Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,835.13 -41.92 (-0.53%) Bitcoin USD
64,869.54 +3,282.81 (+5.33%) CMC Crypto 200
1,333.52 +20.89 (+1.62%)
Kronos Bio, Inc. (KRON)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0400 |
| Open | 1.0299 |
| Bid | 0.9824 x 200 |
| Ask | 1.0600 x 200 |
| Day's range | 1.0000 - 1.0700 |
| 52-week range | 0.7310 - 2.2900 |
| Volume | |
| Avg. volume | 282,979 |
| Market cap | 61.898M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock?
Kronos Bio (KRON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Simply Wall St.
We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates
Kronos Bio, Inc. (KRON) delivered earnings and revenue surprises of -5.88% and 63.32%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.